• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

组织蛋白酶B在老年人脑中的抗原表达。

Antigenic expression of cathepsin B in aged human brain.

作者信息

Bernstein H G, Kirschke H, Wiederanders B, Schmidt D, Rinne A

机构信息

Institute of Anatomy, Medical Academy Magdeburg, GDR.

出版信息

Brain Res Bull. 1990 Apr;24(4):543-9. doi: 10.1016/0361-9230(90)90157-u.

DOI:10.1016/0361-9230(90)90157-u
PMID:2357585
Abstract

The lysosomal thiol proteinase, cathepsin B, has been localized in different regions of aged human brain by use of the peroxidase-antiperoxidase technique. Cathepsin B-immunoreactive material was detected in multiple neurons of human hippocampus, neocortical area A 10, prefrontal gyrus and nuc. basalis of Meynert as well as in single white matter astrocytes. In brains of Alzheimer disease-affected subjects cathepsin B was revealed in neuritic plaques too. Possible functional consequences with regard to normal aging, neuropeptide metabolism and pathological changes are discussed.

摘要

利用过氧化物酶-抗过氧化物酶技术,已将溶酶体硫醇蛋白酶组织蛋白酶B定位在老年人脑的不同区域。在人类海马体、新皮质A10区、前额叶回和迈内特基底核的多个神经元以及单个白质星形胶质细胞中检测到了组织蛋白酶B免疫反应性物质。在受阿尔茨海默病影响的大脑中,神经炎性斑块中也发现了组织蛋白酶B。讨论了其在正常衰老、神经肽代谢和病理变化方面可能的功能后果。

相似文献

1
Antigenic expression of cathepsin B in aged human brain.组织蛋白酶B在老年人脑中的抗原表达。
Brain Res Bull. 1990 Apr;24(4):543-9. doi: 10.1016/0361-9230(90)90157-u.
2
Lysosomal proteinase antigens are prominently localized within senile plaques of Alzheimer's disease: evidence for a neuronal origin.溶酶体蛋白酶抗原显著定位于阿尔茨海默病的老年斑内:神经元起源的证据。
Brain Res. 1990 Apr 16;513(2):181-92. doi: 10.1016/0006-8993(90)90456-l.
3
Immunodetection of cathepsin D in neuritic plaques found in brains of patients with dementia of Alzheimer type.在阿尔茨海默型痴呆患者大脑中发现的神经炎性斑块中组织蛋白酶D的免疫检测。
J Hirnforsch. 1989;30(5):613-8.
4
An immunohistochemical study of cathepsin E in Alzheimer-type dementia brains.阿尔茨海默型痴呆症大脑中组织蛋白酶E的免疫组织化学研究。
Brain Res. 1994 Dec 26;667(2):287-90. doi: 10.1016/0006-8993(94)91509-1.
5
Lysosomal abnormalities in degenerating neurons link neuronal compromise to senile plaque development in Alzheimer disease.退化神经元中的溶酶体异常将神经元损伤与阿尔茨海默病中的老年斑形成联系起来。
Brain Res. 1994 Mar 21;640(1-2):68-80. doi: 10.1016/0006-8993(94)91858-9.
6
Cystatin A-like immunoreactivity is widely distributed in human brain and accumulates in neuritic plaques of Alzheimer disease subjects.胱抑素A样免疫反应性广泛分布于人类大脑中,并在阿尔茨海默病患者的神经炎性斑块中积聚。
Brain Res Bull. 1994;33(5):477-81. doi: 10.1016/0361-9230(94)90071-x.
7
Spatial patterns of mammalian brain aging: distribution of cathepsin D-immunoreactive cell bodies and dystrophic dendrites in aging dogs resembles that in Alzheimer's disease.哺乳动物脑衰老的空间模式:衰老犬中组织蛋白酶D免疫反应性细胞体和营养不良性树突的分布类似于阿尔茨海默病中的分布。
J Comp Neurol. 2003 Sep 22;464(3):371-81. doi: 10.1002/cne.10795.
8
Age-related changes in activities and localizations of cathepsins D, E, B, and L in the rat brain tissues.大鼠脑组织中组织蛋白酶D、E、B和L的活性及定位的年龄相关变化。
Exp Neurol. 1994 Mar;126(1):119-28. doi: 10.1006/exnr.1994.1048.
9
High selective expression of alpha7 nicotinic receptors on astrocytes in the brains of patients with sporadic Alzheimer's disease and patients carrying Swedish APP 670/671 mutation: a possible association with neuritic plaques.α7烟碱型受体在散发性阿尔茨海默病患者及携带瑞典APP 670/671突变患者大脑星形胶质细胞上的高选择性表达:与神经炎性斑块的可能关联
Exp Neurol. 2005 Mar;192(1):215-25. doi: 10.1016/j.expneurol.2004.12.015.
10
Enzymatically active lysosomal proteases are associated with amyloid deposits in Alzheimer brain.具有酶活性的溶酶体蛋白酶与阿尔茨海默病大脑中的淀粉样蛋白沉积有关。
Proc Natl Acad Sci U S A. 1990 May;87(10):3861-5. doi: 10.1073/pnas.87.10.3861.

引用本文的文献

1
Genetic Insights Into the Role of Cathepsins in Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis: Evidence From Mendelian Randomization Study.组织蛋白酶在阿尔茨海默病、帕金森病和肌萎缩侧索硬化症中作用的遗传学见解:孟德尔随机化研究的证据
Brain Behav. 2025 Jan;15(1):e70207. doi: 10.1002/brb3.70207.
2
Microglia: Friend and foe in tauopathy.小胶质细胞:tau 病中的朋友和敌人。
Prog Neurobiol. 2022 Sep;216:102306. doi: 10.1016/j.pneurobio.2022.102306. Epub 2022 Jun 14.
3
Cathepsin B Gene Knockout Improves Behavioral Deficits and Reduces Pathology in Models of Neurologic Disorders.
组织蛋白酶 B 基因敲除可改善神经疾病模型中的行为缺陷并减少病变。
Pharmacol Rev. 2022 Jul;74(3):600-629. doi: 10.1124/pharmrev.121.000527.
4
New Insights into the Role of Cysteine Cathepsins in Neuroinflammation.半胱氨酸组织蛋白酶在神经炎症中的作用的新见解。
Biomolecules. 2021 Nov 30;11(12):1796. doi: 10.3390/biom11121796.
5
Dissecting the Crosstalk between Endothelial Mitochondrial Damage, Vascular Inflammation, and Neurodegeneration in Cerebral Amyloid Angiopathy and Alzheimer's Disease.解析脑淀粉样血管病和阿尔茨海默病中内皮线粒体损伤、血管炎症和神经退行性变的串扰。
Cells. 2021 Oct 27;10(11):2903. doi: 10.3390/cells10112903.
6
Putative roles of cathepsin B in Alzheimer's disease pathology: The good, the bad, and the ugly in one?组织蛋白酶B在阿尔茨海默病病理学中的假定作用:是集善恶丑于一体?
Neural Regen Res. 2018 Dec;13(12):2100-2101. doi: 10.4103/1673-5374.241457.
7
Cathepsin B is a New Drug Target for Traumatic Brain Injury Therapeutics: Evidence for E64d as a Promising Lead Drug Candidate.组织蛋白酶B是创伤性脑损伤治疗的新药物靶点:E64d作为一种有前景的先导药物候选物的证据。
Front Neurol. 2015 Sep 2;6:178. doi: 10.3389/fneur.2015.00178. eCollection 2015.
8
Cysteine cathepsins in neurological disorders.神经疾病中的半胱氨酸组织蛋白酶
Mol Neurobiol. 2014 Apr;49(2):1017-30. doi: 10.1007/s12035-013-8576-6. Epub 2013 Nov 15.
9
The cysteine protease inhibitor, E64d, reduces brain amyloid-β and improves memory deficits in Alzheimer's disease animal models by inhibiting cathepsin B, but not BACE1, β-secretase activity.半胱氨酸蛋白酶抑制剂 E64d 通过抑制组织蛋白酶 B(cathepsin B),而非 BACE1(β-分泌酶),减少阿尔茨海默病动物模型中的脑淀粉样β并改善记忆缺陷。
J Alzheimers Dis. 2011;26(2):387-408. doi: 10.3233/JAD-2011-110101.
10
Complexes of amyloid-beta and cystatin C in the human central nervous system.人类中枢神经系统中β-淀粉样蛋白与胱抑素C的复合物
J Alzheimers Dis. 2009;18(2):273-80. doi: 10.3233/JAD-2009-1147.